Literature DB >> 9708201

The determination of INR in stored whole blood.

D R Leeming1, S Craig, K J Stevenson, D A Taberner.   

Abstract

AIMS: To examine the reliability of international normalised ratio (INR) determination on samples stored as whole blood for up to two days at room temperature.
METHODS: The INR of 40 patients receiving oral anticoagulants was determined on fresh blood and on samples stored for 24 and 48 hours, using five locally calibrated prothrombin time systems. These incorporated Manchester reagent, Recombiplastin, IL PT Fibrinogen HS Plus, Manchester combined capillary prothrombin time reagent, and a freeze dried in-house reference rabbit brain thromboplastin, RBT 1010. In addition, factors II, V, VII, and X were determined on samples obtained from 18 of these patients before and after incubation at room temperature.
RESULTS: The INR of the samples changed by differing amounts during storage, depending on which system was employed. Although the mean change after 24 hours storage was relatively small, there were individual samples that changed by > 0.5 INR with all systems. These changes would lead to adjustment in dosage of certain patients. After 48 hours these effects were greater with all systems except that employing Recombiplastin. There were only small reduction in the measured factors by 48 hours.
CONCLUSIONS: After storage of samples for only 24 hours, some patients' INR changed sufficiently to affect dosage. In view of these observations, the practice of storing whole blood samples for INR determination cannot be recommended.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9708201      PMCID: PMC500694          DOI: 10.1136/jcp.51.5.360

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  8 in total

1.  Monitoring oral anticoagulation in primary care.

Authors:  D A Fitzmaurice; F D Hobbs; J A Murray
Journal:  BMJ       Date:  1996-06-08

2.  Refrigerated stored specimens are not reliable for delayed INR determination.

Authors:  A González Hernández; J M Martín de Segovia; J Rodríguez Villanueva
Journal:  Br J Haematol       Date:  1997-09       Impact factor: 6.998

3.  Reliability of delayed INR determination: implications for decentralized anticoagulant care with off-site blood sampling.

Authors:  T Baglin; R Luddington
Journal:  Br J Haematol       Date:  1997-03       Impact factor: 6.998

Review 4.  Prevention of thromboembolic events in atrial fibrillation.

Authors:  B G Koefoed; A L Gulløv; P Petersen
Journal:  Thromb Haemost       Date:  1997-07       Impact factor: 5.249

5.  Statistical methods for assessing agreement between two methods of clinical measurement.

Authors:  J M Bland; D G Altman
Journal:  Lancet       Date:  1986-02-08       Impact factor: 79.321

6.  Multi-center study of replacement of the international reference preparation for thromboplastin, rabbit, plain.

Authors:  A M van den Besselaar
Journal:  Thromb Haemost       Date:  1993-11-15       Impact factor: 5.249

7.  Anticoagulation in patients with atrial fibrillation. GPs not prepared for monitoring anticoagulation.

Authors:  F Taylor; M Ramsay; J Voke; H Cohen
Journal:  BMJ       Date:  1993-12-04

8.  Prevalence, age distribution, and gender of patients with atrial fibrillation. Analysis and implications.

Authors:  W M Feinberg; J L Blackshear; A Laupacis; R Kronmal; R G Hart
Journal:  Arch Intern Med       Date:  1995-03-13
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.